Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial
- DOI
- 10.3389/fphar.2026.1927547
- Published
- 2026-10-14
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1927547,
title = {Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial},
author = {Lin Fang and Xin Li and Rongxin Ban and Chenjing Wang and Yi Xu and Lipeng Xue and Ping Shi and Feifei Sun and Yu Cao},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1927547},
url = {https://doi.org/10.3389/fphar.2026.1927547}
}RIS
TY - JOUR TI - Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial AU - Lin Fang AU - Xin Li AU - Rongxin Ban AU - Chenjing Wang AU - Yi Xu AU - Lipeng Xue AU - Ping Shi AU - Feifei Sun AU - Yu Cao PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1927547 UR - https://doi.org/10.3389/fphar.2026.1927547 ER -
APA
Fang, L., Li, X., Ban, R., Wang, C., Xu, Y., Xue, L., Shi, P., Sun, F., & Cao, Y. (2026). Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1927547
Source records
- crossref · retrieved 2026-11-10T21:27:09.740Z